| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $437.1M | +140.8% |
| SG&A Expense | $130.9M | +249.8% |
| Operating Income | -$567.9M | -159.4% |
| Pre-tax Income | -$569.8M | -168.2% |
| Income Tax | $438K | -67.9% |
| Net Income | -$570.3M | -166.7% |
| EPS (Basic) | -$12.75 | -134.8% |
| EPS (Diluted) | -$12.75 | -134.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $204.9M | +169.4% |
| Short-term Investments | $260.5M | — |
| Current Assets | $587.0M | +519.0% |
| Total Assets | $661.8M | +365.8% |
| Current Liabilities | $90.0M | +114.7% |
| Total Liabilities | $123.0M | +159.7% |
| Stockholders' Equity | $538.8M | +1453.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$297.7M | -104.1% |
| Capital Expenditures | $6.1M | +547.5% |
| Investing Cash Flow | -$304.8M | — |
| Financing Cash Flow | $767.6M | +454.4% |
| Free Cash Flow | -$303.8M | -107.0% |